If you need more lookups,
subscriptions start at $34 USD/month.
Y.s. Hong Location
South Korea
Y.s. Hong Work
2023 -now Chief Executive Officer @
2021 -2023 Chief Executive Officer @
2020 -2021 Vice President, Medicine Commercialization Leader Linerixibat and Special Projects @
2018 -2020 President, General Manager Pharmaceutical @ GSK Canada
2014 -2018 Vice President and General Manager Pharmaceuticals @ GSK Korea
2016 -2018 Vice Chair, BoD director @ KRPIA (Korean Research-based Pharmaceutical Industry Association)
2013 -2014 CEO and General Manager @ Teva-Handok
2008 -2013 Senior Director of Strategy, Emerging Market Business Unit @ Eli Lilly and Company
2007 -2008 General Manager @ Eli Lilly and Company
2005 -2007 International Brand Leader, Osteoporosis @ Eli Lilly and Company
2003 -2004 District Sales Manager, Neuroscience Retail @ Eli Lilly and Company
2001 -2003 Sales and Marketing Director @ Lilly Korea
2000 -2001 Marketing Director @ Lilly Korea
1998 -1999 New Product Planning Manager @ Lilly Korea
1996 -1997 CNS Business Unit Head @ Daewoong Lilly
1994 -1996 Business Development Manager @ Daewoong Lilly
1994 -1994 Sales Representative @ Eli Lilly and Company
1992 -1994 Financial Analyst, Staff Auditor, Treasury Analyst @ Eli Lilly and Company
1988 -1990 Finance Associate, International Business Department @ Dongsuh Securities
Y.s. Hong Education
The Wharton School
Master of Business Administration (M.B.A.) (Finance, General)
1990-1992
Hankook University of Foreign Studies
B.A.
1983-1988
Y.s. Hong Summary
Y.s. Hong, based in South Korea, is currently a Chief Executive Officer at Genome & Company. Y.s. Hong brings experience from previous roles at D&D Pharmatech, GSK, GSK Canada and GSK Korea. Y.s. Hong holds a 1990 - 1992 Master of Business Administration (M.B.A.) in Finance, General @ The Wharton School. Y.s. Hong has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Y.s. Hong?
Find contact details for 700 million professionals.